Pooled cohort data indicate that mortality and cardiovascular benefits associated with daily step counts rise steeply up to roughly 7,000 steps and then plateau.

The finding challenges the widely promoted 10,000-step target, which originated in marketing rather than research.

Public health researchers say the more useful message is that any increase from a low baseline delivers the largest relative gain.